streptoCARE B

Approximately 40% of neonatal infections in the first three days are caused by streptoccus B. The progression is often serious and can lead to meningitis and septic shock. In approximately 50% of babies born to mothers with either a vaginal or an rectal infection this leads to a colonialization. Very often premature babies are effected, which means that an early diagnosis in the pregnant woman is extremely important.

The new streptoCARE B quick test detects a streptococcal B infection within a very short space of time compared to the cell culture method. Incubation at 80° C is also no longer necessary. The test result is ready in 15 minutes and the purple lines are easy to see. Clinical studies prove the reliability of this test result; the test detects a streptococcal B infection at a level of 5x105 CFU/ml.

Another area for use is for the early diagnosis of streptococcus B in newborn babies. The quick test performed on a gastric secretion sample has been successful in clinical trials. The results lead us to recommend streptoCARE B test for such cases. StreptoCARE B's simplicity increases the quality of patient management, and at the same time enables effective use with small as well as large sample volumes.

Advantages:

• easy to perform
• fast test result (within 10 min)
• specificity: 92,0%
• sensitivity: 90,2%